Burchiel Named First Chair of Pharmacogenomics
March 26, 2007
Contact: Lauren Cruse (505) 272-3690
FOR IMMEDIATE RELEASE
Dr. Scott ALBUQUERQUE, N.M. - Dr. Scott W. Burchiel has been named the first chair holder of the Nunzio and Sherolyn De Santis Endowed Chair in Pharmacogenomics at the University of New Mexico College of Pharmacy.
Pharmacogenomics is the science that examines the inherited variations in genes that dictate drug response and explores the ways these variations can be used to predict whether a patient will have a good response to a drug, a bad response, or no response at all.
In 1992, Nunzio and Sherolyn De Santis donated stock from their company Diagnostic to establish an endowed chair at the UNM College of Pharmacy. Nunzio De Santis is a 1974 graduate of the UNM College of Pharmacy and one of the first board certified nuclear pharmacists in the U.S.
Dr. Burchiel has been a faculty member at UNM for 29 years. He is a professor of pharmacology and toxicology as well as the associate dean for research at the UNM College of Pharmacy. Dr. Burchiel also serves as the associate vice president for advanced studies at UNM. His expertise includes immunotoxicology, environmental carcinogenesis and breast cancer research.
"The College of Pharmacy is excited to name the holder of the first endowed chair in our history," said UNM College of Pharmacy Dean John Pieper. "Nunzio De Santis’ gift has allowed us to support the significant research of Dr. Burchiel and to establish the College of Pharmacy at UNM as a leading center for pharmacogenomics research."